Orange Book product · Generic (ANDA)
GUANFACINE HYDROCHLORIDE
GUANFACINE HYDROCHLORIDE
At a glance
Apr 15, 2025
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 15, 2025
1 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
GUANFACINE HYDROCHLORIDE
Strength
EQ 1MG BASE
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
TE code
AB
Application
ANDA 219689
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GUANFACINE HYDROCHLORIDE
- 2009INTUNIVBrand (NDA)
NDA 022037 · TAKEDA PHARMS USA
- 1986TENEXBrand (NDA)
NDA 019032 · PROMIUS PHARMA
- 2026GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 220675 · ASCENT PHARMS INC
- 2024GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 219033 · UNICHEM
- 2024GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217638 · FOSUN WANBANG
- 2024GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218326 · XIROMED
- 2023GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216762 · RUBICON RESEARCH
- 2023GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216828 · I 3 PHARMS
- 2023GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217269 · ALEMBIC
- 2023GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217293 · AJANTA PHARMA LTD
- 2022GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 216399 · AIPING PHARM INC
- 2021GUANFACINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214689 · UNICHEM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

